tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

OptimizeRx sees FY25 revenue $101M-$106M, consensus $101.26M

Sees FY25 adjusted EBITDA between $13M-$15M.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1